Literature DB >> 18421194

Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia.

Kanji Sato1, Yoko Omi, Hitomi Kodama, Takao Obara, Kazuko Yamazaki, Emiko Yamada, Toshiro Seki, Kazue Takano, Tsuyoshi Shiga, Hiroshi Kasanuki.   

Abstract

We report the treatment of four thyrotoxic patients. Two were cases of type I amiodarone-induced thyrotoxicosis (AIT) treated with methimazole. The third Graves' disease patient, who became hypothyroid 25 years after subtotal thyroidectomy, developed type II AIT. Furthermore, one case with heart failure and ventricular tachycardia, who developed an adverse reaction to antithyroid agents and was prescribed amiodarone, underwent total thyroidectomy. The clinical course was uneventful, and the patient is doing well. Since amiodarone contains a large amount of iodine, it is frequently difficult to make a differential diagnosis. Surgical treatment of Graves' disease patients is recommended when immediate control of hyperthyroidism and heart failure is required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421194     DOI: 10.2169/internalmedicine.47.0843

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Successful Treatment of Amiodarone-induced Thyrotoxicosis Type 1 in Combination with Methimazole and Potassium Iodide in a Patient with Hashimoto's Thyroiditis.

Authors:  Daisuke Katoh; Hiroshi Yoshino; Kayoko Ikehara; Naoki Kumashiro; Hiroshi Uchino; Kumiko Tsuboi; Takahisa Hirose
Journal:  Intern Med       Date:  2019-09-26       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.